does harvard pilgrim cover semaglutide Point32Health reports hefty losses in 2025 driven by GLP-1 weight-loss drugs 1 Point32Health, parent company of

NAION = non-arteritic anterior ischemic optic neuropathy is a rare cause of blindness and has been reported at higher rates in those taking GLP1s

Minimizing side effects like stomach upset means focusing on nutrient-rich, easily digestible meals

Ozempic face and facial aging have been observed as side effects in many patients after glucagon like peptide 1 receptor agonists (GLP-1RA) therapy for type 2 diabetes mellitus (T2DM) and obesity

But a humble prebiotic may nudge the same hormone the blockbuster drugs target - here's what the science actually says.

Download the FASTer Way guide to avoid common mistakes that impact muscle, metabolism, and long-term health.

HPLC-verified, batch-specific COA